NCT00990613
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +17 more
- Locations
-
- Pfizer Investigational Site Kalamazoo, Michigan, United States
Clinical trial condition
Explore clinical trials studying Cognition Disorders. Study availability and eligibility vary by location and protocol.
NCT00990613
NCT00988624
NCT00000173
NCT00097630
NCT00000180
NCT00931073
NCT00506818
NCT00979446
NCT00249080
Not specified